1-(2,5-dimethoxy-4-ethylphenyl)propan-2-amine
GPTKB entity
Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
amphetamine |
| gptkbp:CASNumber |
6418-89-5
|
| gptkbp:class |
amphetamine
psychedelic recreational drug |
| gptkbp:describedBy |
gptkb:PiHKAL
|
| gptkbp:duration |
8-12 hours
|
| gptkbp:effect |
euphoria
hallucinations altered perception stimulation |
| gptkbp:hasCommonDosageRange |
10-25 mg
|
| gptkbp:hasMinimumDosage |
10 mg
|
| gptkbp:hasMolecularFormula |
C13H21NO2
|
| gptkbp:hasSMILES |
CCc1cc(OC)c(cc1OC)CC(N)C
|
| https://www.w3.org/2000/01/rdf-schema#label |
1-(2,5-dimethoxy-4-ethylphenyl)propan-2-amine
|
| gptkbp:isSchedule |
gptkb:Schedule_III_(Canada)
gptkb:Class_A_(UK) Schedule I (USA) |
| gptkbp:isStructurallyRelatedTo |
gptkb:2C-B
gptkb:2C-D gptkb:2C-I mescaline |
| gptkbp:IUPACName |
gptkb:1-(2,5-dimethoxy-4-ethylphenyl)propan-2-amine
|
| gptkbp:otherName |
gptkb:2C-E
|
| gptkbp:psychoactive |
true
|
| gptkbp:PubChem_CID |
1447
|
| gptkbp:synonym |
gptkb:2C-E
|
| gptkbp:wasSynthesizedBy |
gptkb:Alexander_Shulgin
|
| gptkbp:bfsParent |
gptkb:F.E.2a
|
| gptkbp:bfsLayer |
7
|